JPS6152151B2 - - Google Patents
Info
- Publication number
- JPS6152151B2 JPS6152151B2 JP7706084A JP7706084A JPS6152151B2 JP S6152151 B2 JPS6152151 B2 JP S6152151B2 JP 7706084 A JP7706084 A JP 7706084A JP 7706084 A JP7706084 A JP 7706084A JP S6152151 B2 JPS6152151 B2 JP S6152151B2
- Authority
- JP
- Japan
- Prior art keywords
- vef
- ferulic acid
- tocopherol
- benzene
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 10
- 229940114124 ferulic acid Drugs 0.000 claims description 10
- 235000001785 ferulic acid Nutrition 0.000 claims description 10
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 10
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 10
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 4
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- -1 tocopherol ferulic acid ester Chemical class 0.000 claims description 3
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7706084A JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7706084A JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60222476A JPS60222476A (ja) | 1985-11-07 |
| JPS6152151B2 true JPS6152151B2 (enrdf_load_stackoverflow) | 1986-11-12 |
Family
ID=13623246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7706084A Granted JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60222476A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002284625A (ja) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | 化粧料 |
-
1984
- 1984-04-17 JP JP7706084A patent/JPS60222476A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60222476A (ja) | 1985-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10981854B2 (en) | Method for purification of 4-hydroxyacetophenone | |
| WO1994029404A1 (fr) | Compositions de derives de polyphenols et leur preparation | |
| JP2007259866A (ja) | ホスファチドの製造と使用 | |
| JPH053453B2 (enrdf_load_stackoverflow) | ||
| WO2009062662A1 (en) | Pharmaceutical and nutraceutical compositions based on menaquinols | |
| CA2628304C (en) | Method of refining episesamin | |
| JPS6152151B2 (enrdf_load_stackoverflow) | ||
| JPH0432073B2 (enrdf_load_stackoverflow) | ||
| JPH05255367A (ja) | カンタリジン誘導体組成物の製造法及びそれを含む抗ウイルス剤 | |
| JP2002205949A (ja) | 代謝異常改善方法およびそのための組成物 | |
| JPS6388159A (ja) | ドコサヘキサエン酸エステルの製造法 | |
| US4025631A (en) | Dihydroquinoline derivatives of antioxidant activity | |
| US4046765A (en) | Dihydroquinoline derivatives of antioxidant activity and a process for the preparation thereof | |
| JPS621396B2 (enrdf_load_stackoverflow) | ||
| JPH10287582A (ja) | 樹皮抽出物からなるヒスタミン遊離抑制剤 | |
| JPS5940179B2 (ja) | 酸化防止剤 | |
| CN112375008A (zh) | 一种花生四烯酸乙醇胺的合成和纯化方法 | |
| LU84429A1 (fr) | A titre de medicaments,certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| US2912360A (en) | Process for obtaining intrinsic factor | |
| CN108892660A (zh) | 一种阿折地平杂质b的制备方法 | |
| RU2141334C1 (ru) | Способ получения средства "олипифат" для лечения неонкологических патологий организма | |
| JPH10306032A (ja) | 精力増強剤 | |
| RU2178303C1 (ru) | Антиоксидантное и антирадикальное средство | |
| JPH02503792A (ja) | 副腎白質ジストロフィーを治療するための医薬組成物 | |
| JPS62187470A (ja) | トコフエロ−ル／トコトリエノ−ル−ｌ−アスコルビン酸−６−ジカルボン酸ジエステル及びその製造方法並びにそれを有効成分とする薬剤 |